Botox for the Treatment of Recurrent Chronic Exertional Compartment Syndrome
Status:
Not yet recruiting
Trial end date:
2023-10-01
Target enrollment:
Participant gender:
Summary
10 participants with Recurrent Chronic Exertional Compartment Syndrome (R-CECS) will be
enrolled in a 6 month study at the University of Wisconsin Hospitals and Clinics to test the
hypothesis that injection of Botox into the affected muscle group will alleviate pain
associated with R-CECS.